188 related articles for article (PubMed ID: 31737140)
21. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
22. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
[TBL] [Abstract][Full Text] [Related]
23. (68)Ga-DOTATATE positron emission tomography/computed tomography scan in the detection of bone metastases in pediatric neuroendocrine tumors.
Goel R; Shukla J; Bansal D; Sodhi K; Bhattacharya A; Marwaha RK; Mittal BR
Indian J Nucl Med; 2014 Jan; 29(1):13-7. PubMed ID: 24591776
[TBL] [Abstract][Full Text] [Related]
24. Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on
Zidan L; Iravani A; Kong G; Akhurst T; Michael M; Hicks RJ
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):204-216. PubMed ID: 32572559
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine Tumor Diagnosis and Management:
Sanli Y; Garg I; Kandathil A; Kendi T; Zanetti MJB; Kuyumcu S; Subramaniam RM
AJR Am J Roentgenol; 2018 Aug; 211(2):267-277. PubMed ID: 29975116
[TBL] [Abstract][Full Text] [Related]
26. Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging (
Loharkar S; Basu S
World J Nucl Med; 2021; 20(1):125-128. PubMed ID: 33850504
[TBL] [Abstract][Full Text] [Related]
27. A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis.
Kunikowska J; Pawlak D; Kolasa A; Mikołajczak R; Królicki L
Clin Nucl Med; 2014 Oct; 39(10):855-61. PubMed ID: 25072928
[TBL] [Abstract][Full Text] [Related]
28. Metastatic clear cell renal cell carcinoma demonstrating intense uptake on
Nadebaum DP; Lee ST; Nikfarjam M; Scott AM
World J Nucl Med; 2018; 17(3):195-197. PubMed ID: 30034285
[No Abstract] [Full Text] [Related]
29.
El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on
Ninatti G; Duan H; Ferri V; Martin BA; Aparici CM
Radiol Case Rep; 2020 Dec; 15(12):2698-2700. PubMed ID: 33117470
[TBL] [Abstract][Full Text] [Related]
31. 68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients.
Fendler WP; Barrio M; Spick C; Allen-Auerbach M; Ambrosini V; Benz M; Bluemel C; Grewal RK; Lapa C; Miederer M; Nicolas G; Schuster T; Czernin J; Herrmann K
J Nucl Med; 2017 Feb; 58(2):307-311. PubMed ID: 27539839
[TBL] [Abstract][Full Text] [Related]
32. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
[TBL] [Abstract][Full Text] [Related]
33. Metastatic Neuroendocrine Tumor with Extensive Bone Marrow Involvement at Diagnosis: Evaluation of Response and Hematological Toxicity Profile of PRRT with (177)Lu-DOTATATE.
Basu S; Ranade R; Thapa P
World J Nucl Med; 2016; 15(1):38-43. PubMed ID: 26912977
[TBL] [Abstract][Full Text] [Related]
34. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of a three-scale grading system based on combining molecular imaging with
Karfis I; Marin G; Levillain H; Drisis S; Muteganya R; Critchi G; Taraji-Schiltz L; Guix CA; Shaza L; Elbachiri M; Mans L; Machiels G; Hendlisz A; Flamen P
Oncotarget; 2020 Feb; 11(6):589-599. PubMed ID: 32110279
[TBL] [Abstract][Full Text] [Related]
36. Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
Ozkan ZG; Kuyumcu S; Uzum AK; Gecer MF; Ozel S; Aral F; Adalet I
Nucl Med Commun; 2015 Mar; 36(3):242-50. PubMed ID: 25369749
[TBL] [Abstract][Full Text] [Related]
37. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
38. Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.
Janssen I; Blanchet EM; Adams K; Chen CC; Millo CM; Herscovitch P; Taieb D; Kebebew E; Lehnert H; Fojo AT; Pacak K
Clin Cancer Res; 2015 Sep; 21(17):3888-95. PubMed ID: 25873086
[TBL] [Abstract][Full Text] [Related]
39. The role of [
Aloj L; Giger O; Mendichovszky IA; Challis BG; Ronel M; Harper I; Cheow H; Hoopen RT; Pitfield D; Gallagher FA; Attili B; McLean M; Jones RL; Dileo P; Bulusu VR; Maher ER; Casey RT
EJNMMI Res; 2021 Jan; 11(1):5. PubMed ID: 33443647
[TBL] [Abstract][Full Text] [Related]
40. The Utility of
Jaiswal SK; Sarathi V; Malhotra G; Verma P; Hira P; Badhe P; Memon SS; Barnabas R; Patil VA; Anurag ; Lila R; Shah NS; Bandgar T
Indian J Endocrinol Metab; 2021; 25(5):410-417. PubMed ID: 35300451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
